News & Events

Meet ClinSoft Clinical Research on 21st-23rd June at CPhI China 2016

June 3, 2016- Chandigarh: ClinSoft team member will be attending the 3 day CPhI 2016 conference in Shanghai, China. CPhI China is the most comprehensive pure pharma focused event for domestic and international pharmaceutical companies in Asia.  ....................
Read More



Clinical Trial Involving Regenerative Cell Treatment for Patients with Traumatic Brain Injury Permitted in Japan

A Scientific leader in regenerative medicine for neurological disorders and the United States subsidiary of SanBio Co., Ltd., announced today that they are now able to conduct the world’s first global Phase 2 clinical trial for chronic traumatic br....................
Read More



Norms for clinical trials eased

Govt. exempts academic institutions from taking DCGI permission; move a setback, say health experts With the aim to speed up innovation and research in India, the Health Ministry has amended the Drug and Cosmetics Act, exempting clinical trials cond....................
Read More



FDA approves new treatment for inhalation anthrax

The FDA has approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim also is approved to prevent inhalational anthrax when alternative therapies are not available or not appro....................
Read More



ClinSoft Clinical Research Conducting Placement Drive on April 10, 2016 at I.S.F. College of Pharmacy, Moga, Punjab

Chandigarh, April 5, 2016: ClinSoft Clinical Research will be participating in the 2nd National Mega Pharma Job Fest- Cum Placement Drive 2016. ClinSoft will be hiring for multiple positions and vacancies. The Job Fest is open to pha....................
Read More



Triple-Therapy Treatment May Fight Resistant Lung Cancers: Study

WASHINGTON:  A triple therapy treatment consisting of two experimental drugs and radiation therapy may help fight lung cancers that are resistant to current treatments, a new study has claimed. Although the most common type of lung cancer - non-....................
Read More



Nerve damage in MS could be prevented with epilepsy drug

In a study published in The Lancet Neurology, researchers found that an anti-seizure drug called phenytoin protected against nerve damage in people with optic neuritis. Optic neuritis is a common symptom of MS, in which the optic nerve t....................
Read More



Immunotherapy could benefit patients with advanced non-small-cell lung cancer

Promising results from a clinical trial show more patients with advanced non-small-cell lung cancer could benefit from the immunotherapy drug pembrolizumab. In the trial, compared with chemotherapy, the immunotherapy drug improved survival in all pat....................
Read More



2016: The Year of Diversity in Clinical Trials

Controlled clinical trials provide a critical base of evidence for evaluating whether a medical product is effective before the product is approved for marketing. One challenge that remains for FDA is ensuring that research participants are represent....................
Read More



ad1-300x75

SCOPE 2016 SUMMIT FOR CLINICAL OPERATIONS EXECUTIVES

EXHIBIT SHOW DATES: FEBRUARY 23-25, 2016 MIAMI, FL, UNITED STATES

The 7th Annual SCOPE Summit, taking place February 23-25, 2016 in Miami, FL, will focused on issues related to each aspect of clinical trial planning and management: Data Int....................
Read More



img12

CDISC (USA)

Exhibit Show Dates: November 10-14, 2014 Bethesda, MD

....................
Read More



img11

SCDM 2014 Annual Conference Meeting

Exhibit Show Dates: September 28 – October 1, 2014 Las Vegas, NV

Please come and meet with our functional outsourcing team experts representing SCDM 2014 Annual Conference Meeting and learn more about our customer case studies. Event Dat....................
Read More



Quick Enquiry





Back to Top